Transcranial Magnetic Stimulation (TMS) | Brain & Behavior Research Foundation

Home

Home

Grants

BBRF Young Investigator Grants

BBRF Independent Investigator Grants

BBRF Distinguished Investigator Grants

Prizes & Awards

Klerman & Freedman Prizes

Outstanding Achievement Prizes

Lieber Prize for Schizophrenia Research

Maltz Prize for Schizophrenia Research

Colvin Prize for Mood Disorders Research

Ruane Prize for Child and Adolescent Psychiatric Research

Goldman-Rakic Prize for Cognitive Neuroscience Research

The Pardes Humanitarian Prize

Productive Lives Awards

About Us

Media Center

Multimedia Library

Events & Webinars

Team Up for Research! Events

Healthy Minds TV

Rapid-Acting Brain Stimulation Method May Reduce Major Depression by Reversing Information Flow Between Brain Regions

Rapid-Acting Brain Stimulation Method May Reduce Major Depression by Reversing Information Flow Between Brain Regions

In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major... Read More

Study Indicates How rTMS Treatments Alter Neural Connectivity Brain-Wide in Treatment-Resistant Depressed Patients, a Clue to Predict Who Will Benefit

Study Indicates How rTMS Treatments Alter Neural Connectivity Brain-Wide in Treatment-Resistant Depressed Patients, a Clue to Predict Who Will Benefit

Over the last decade, rTMS (repetitive transcranial magnetic stimulation), a form of non-invasive brain stimulation, has become a first-line treatment... Read More

Brain Network Analysis Reveals a Depression – Multiple Sclerosis Connection

Brain Network Analysis Reveals a Depression – Multiple Sclerosis Connection

Depression among people diagnosed with multiple sclerosis (MS) has been estimated to be about three times more common than in... Read More

Two Forms of Non-Invasive Brain Stimulation Helped Older Adults with Treatment-Resistant Depression

Two Forms of Non-Invasive Brain Stimulation Helped Older Adults with Treatment-Resistant Depression

Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks... Read More

FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression

FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression

On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach... Read More

1
2
3
4
5
next ›
last »

Donate Now